Vyzulta Now Approved Website Dec 1, 2017Nov 30, 2017 Brand: Vyzulta (latanoprostene bunod ophthalmic solution), Drops Parent Company: Bausch & Lomb Drug Type: Prescription Drug Category: Ophthalmology Campaign: now-approved Targeting: HCPs Patient Website: http://www.vyzulta.com HCP Website: http://www.vyzulta.com/hcp/ Desktop Mobile Subscription Confirmation